Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BMEA Biomea Fusion, Inc.

Post-Mkt 10-13 17:07:30 EDT

1.26

-0.10

-7.35%

盘后0.9400

-0.32-25.40%

17:07 EDT

High1.44	Low1.23	Vol6.96M
Open1.44	D1 Closing1.36	Amplitude15.20%
Mkt Cap91.10M	Tradable Cap87.80M	Total Shares72.30M
T/O8.73M	T/O Rate9.99%	Tradable Shares69.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BMEA","market":"US","secType":"STK","nameCN":"Biomea Fusion, Inc.","latestPrice":1.26,"timestamp":1791921600000,"preClose":1.36,"halted":0,"volume":6964079,"hourTrading":{"tag":"盘后","latestPrice":0.94,"preClose":1.26,"latestTime":"17:07 EDT","volume":1353392,"amount":1344734.58145264,"timestamp":1791925637246,"change":-0.32,"changeRate":-0.253968,"amplitude":0.363254},"delay":0,"changeRate":-0.07352941176470594,"floatShares":69685200,"shares":72299440,"eps":-0.471065,"marketStatus":"Post-Mkt","change":-0.1,"latestTime":"10-13 17:07:30 EDT","open":1.435,"high":1.4367,"low":1.23,"amount":8725065.4609009,"amplitude":0.151985,"askPrice":1.02,"askSize":200,"bidPrice":0.93,"bidSize":1300,"shortable":3,"etf":0,"ttmEps":-0.471065,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791936000000},"marketStatusCode":4,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":1.36,"preHourTrading":{"tag":"盘前","latestPrice":1.43,"preClose":1.36,"latestTime":"09:29 EDT","volume":197253,"amount":284226.8579262,"timestamp":1791898148595,"change":0.07,"changeRate":0.051471,"amplitude":0.102941},"postHourTrading":{"tag":"盘后","latestPrice":0.94,"preClose":1.26,"latestTime":"17:07 EDT","volume":1353392,"amount":1344734.58145264,"timestamp":1791925637246,"change":-0.32,"changeRate":-0.253968,"amplitude":0.363254},"volumeRatio":3.524488,"impliedVol":1.7871,"impliedVolPercentile":0.7809},"requestUrl":"/m/hq/s/BMEA/tweets","defaultTab":"tweets","newsList":[{"id":"2675936362","title":"Biomea Fusion: in an Additional Fifth Cohort Conducted Under Confinement, at Day 29, Mean Weight Reduction Averaged About 1.55 Kg Per Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2675936362","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675936362?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:08","pubTimestamp":1791922081,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA9TDJLW:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMEA","BK4585","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675836291","title":"Biomea Fusion: Confinement Appears to Have Affected Eating Behavior for Cohort 5 Participants, Believe Its Results Should be Interpreted Separately","url":"https://stock-news.laohu8.com/highlight/detail?id=2675836291","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675836291?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:08","pubTimestamp":1791922081,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA9TDJLW:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BMEA","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675626373","title":"Biomea Fusion - no Increased Alt or Ast Adverse Events Reported in Bmf-650 Phase 1 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2675626373","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675626373?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:08","pubTimestamp":1791922081,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA9TDJLW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","BK4539","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362655","title":"Biomea Fusion - All Adverse Events in Five Mad Cohorts were Mild or Moderate","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675362655?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:08","pubTimestamp":1791922081,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA9TDJLW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","BK4539","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362634","title":"Biomea Fusion - Phase 1 Bmf-650 Shows 1.5%-3.2% Mean Weight Reduction at Day 29 in Cohorts 1-4","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675362634?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:08","pubTimestamp":1791922081,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA9TDJLW:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4539","BK4139","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362632","title":"Biomea Fusion - Rapid One-Step Titration to 400 Mg Qd Well Tolerated in Cohort 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362632","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675362632?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:08","pubTimestamp":1791922081,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA9TDJLW:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BMEA","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675800528","title":"Biomea Fusion to Release Phase I Results for Oral GLP-1 Agonist BMF-650 on Oct. 13","url":"https://stock-news.laohu8.com/highlight/detail?id=2675800528","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675800528?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:31","pubTimestamp":1791837071,"startTime":"0","endTime":"0","summary":"Biomea Fusion to release Phase I results for oral GLP-1 agonist BMF-650 on Oct. 13Biomea Fusion scheduled Phase I results for BMF-650, an oral small-molecule GLP-1 receptor agonist, for Oct. 13, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nNDLb97nN8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NDAQ","SG9999014021.USD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","BK4539","BK4112","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","BCDF","LU0314104364.USD","BK4139","SG9999014039.USD","SG9999014013.SGD","LU2095319765.USD","BK4588","IE00BN0W2V16.EUR","BMEA","SG9999014005.SGD","IE00BN0W2W23.USD","LU2210150020.SGD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675005378","title":"Biomea Fusion to Announce Phase I Results for Bmf-650, Its Next-Generation Oral Small-Molecule Glp-1 Receptor Agonist","url":"https://stock-news.laohu8.com/highlight/detail?id=2675005378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675005378?lang=en_us&edition=fundamental","pubTime":"2026-10-13 04:30","pubTimestamp":1791837008,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nTUA6HFKPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4585","BK4139","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673019679","title":"Biomea Fusion Price Target Announced at $10.00/Share by Brookline Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673019679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673019679?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:10","pubTimestamp":1791385800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BMEA/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669543394","title":"Biomea Fusion Shares Fall After Terminating Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2669543394","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669543394?lang=en_us&edition=fundamental","pubTime":"2026-09-24 02:22","pubTimestamp":1790187746,"startTime":"0","endTime":"0","summary":"Biomea Fusion  shares were down over 19% in Wednesday trading after the company said it terminated its proposed public offering of securities announced Tuesday.The termination follows management's evaluation that current market conditions are not conducive to offering terms that would be in the best interests of its stockholders, the company said.No securities were sold in connection with the proposed offering.Price: 1.38, Change: -0.33, Percent Change: -19.12","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4585","BMEA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480190","title":"Biomea Fusion Completes Phase 1 BMF-500 Trial in Acute Leukemia: What Investors Should Watch Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480190","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480190?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:30","pubTimestamp":1790181015,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc ($BMEA) announced an update on their ongoing clinical study. Biomea Fusion Inc. is running a Phase 1 study called “A Phase 1, Ope...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-completes-phase-1-bmf-500-trial-in-acute-leukemia-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-completes-phase-1-bmf-500-trial-in-acute-leukemia-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","ISBC","BMEA","BK4539","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122740","title":"Biomea Fusion Updates Timeline for BMF-650 Phase I Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122740","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122740?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:38","pubTimestamp":1790109515,"startTime":"0","endTime":"0","summary":"Biomea Fusion ( ($BMEA) ) has provided an update. On September 22, 2026, Biomea Fusion, Inc. reported an updated timeline for topline results from ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-updates-timeline-for-bmf-650-phase-i-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-updates-timeline-for-bmf-650-phase-i-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA","BK4585","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122737","title":"Biomea Fusion announces offering of common stock and warrants, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122737","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122737?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:16","pubTimestamp":1790108172,"startTime":"0","endTime":"0","summary":"Biomea Fusion (BMEA) announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-announces-offering-of-common-stock-and-warrants-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-announces-offering-of-common-stock-and-warrants-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BMEA","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122854","title":"Biomea Fusion Launches Underwritten Public Offering of Common Stock, Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122854","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122854?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:06","pubTimestamp":1790107604,"startTime":"0","endTime":"0","summary":"Biomea Fusion launches underwritten public offering of common stock, pre-funded warrantsBiomea Fusion launched an underwritten public offering of common stock, with pre-funded warrants available in li","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL6Znsrh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4139","IE00BQXX3F31.USD","SG9999014039.USD","SG9999014021.USD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","BK4539","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014005.SGD","BK4588","LU2210150020.SGD","IE00BQXX3C00.GBP","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","BK4585","NDAQ","BMEA","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669124015","title":"Biomea Fusion Announces Proposed Public Offering of Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2669124015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669124015?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:05","pubTimestamp":1790107501,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA20XGZ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BMEA","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669124082","title":"Biomea Fusion - Topline Results from Phase I Glp-131 Trial for Bmf-650 Expected in October 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669124082","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669124082?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:02","pubTimestamp":1790107340,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0OA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","BMEA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664779048","title":"Biomea Fusion to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664779048","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664779048?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Company” or “Company management”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355833/0/en/biomea-fusion-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA","BK4539","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663972420","title":"Biomea Fusion Completes Key Phase 2 Trial in Type 1 Diabetes: What Investors Should Watch Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2663972420","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663972420?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934613,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc ($BMEA) announced an update on their ongoing clinical study. Biomea Fusion Inc. has completed a mid-stage study of BMF-219 in adu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-completes-key-phase-2-trial-in-type-1-diabetes-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-completes-key-phase-2-trial-in-type-1-diabetes-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ISBC","BK4139","BMEA","BK4211","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203426","title":"Biomea Shares Rise After Completing Enrollment in Diabetes Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203426","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203426?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:47","pubTimestamp":1787597276,"startTime":"0","endTime":"0","summary":"Biomea Fusion  shares rose over 14% in Monday trading after the firm said it has completed enrollment in a phase 2 trial of icovamenib in insulin-deficient Type 2 diabetes patients.The clinical-stage firm said topline 26-week primary endpoint data from the COVALENT-211 trial is expected in Q1 of 2027.Biomea also said COVALENT-212 mid-stage trial enrollment is still ongoing, with topline 26-week primary endpoint data anticipated in Q2 of 2027.Price: 1.57, Change: +0.20, Percent Change: +14.60","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BMEA","BK4139","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271007","title":"Unusually active option classes on open August 24th","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271007?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:40","pubTimestamp":1787578821,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: Biomea Fusion (BMEA), Vale (VALE), 21Vianet (VNET), Tractor Supply (TSCO), Humana (HUM), Pindu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-august-24th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-august-24th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1917777945.USD","BK4533","LU0348723411.USD","IHF","VNET","BK4154","HUM","LU0072463663.USD","LU0531970944.HKD","IE00B3M56506.USD","LU1941712264.USD","LU0390134368.USD","BK4607","LU0256859116.SGD","BK4548","FXH","BK4566","LU1974910355.USD","BK4531","BK4516","IE00B1B80R65.USD","LU0417517546.SGD","LU0106259046.USD","LU0788109121.HKD","SG9999014005.SGD","SG9999014013.SGD","BMEA","LU0075056555.USD","LU0265266980.USD","LU0238689110.USD","LU0266013472.USD","BK4585","LU0211331839.USD","LU0070302665.USD","LU0254981946.USD","VALE","LU0572108347.SGD","VALG","LU0256863811.USD","SLX","LU0612318385.USD","LU1941712348.USD","LU0320765489.SGD","LU0788109048.HKD","LU1046422090.SGD","BK4200","TSCO","LU0265267285.USD","LU0823046494.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomeafusion.com","stockEarnings":[{"period":"1week","weight":0.0462},{"period":"1month","weight":-0.2184},{"period":"3month","weight":0.0543},{"period":"6month","weight":-0.3096},{"period":"1year","weight":-0.1905},{"period":"ytd","weight":0.0968}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.0181},{"period":"3month","weight":0.0349},{"period":"6month","weight":0.1117},{"period":"1year","weight":0.1915},{"period":"ytd","weight":0.141}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.06322},{"month":2,"riseRate":0.4,"avgChangeRate":0.025302},{"month":3,"riseRate":0.4,"avgChangeRate":0.163799},{"month":4,"riseRate":0,"avgChangeRate":-0.156763},{"month":5,"riseRate":0.666667,"avgChangeRate":0.113922},{"month":6,"riseRate":0.5,"avgChangeRate":0.078877},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.050106},{"month":8,"riseRate":0.833333,"avgChangeRate":0.137883},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.045065},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.101956},{"month":11,"riseRate":0.4,"avgChangeRate":-0.034764},{"month":12,"riseRate":0.4,"avgChangeRate":-0.114655}],"exchange":"NASDAQ","name":"Biomea Fusion, Inc.","nameEN":"Biomea Fusion, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biomea Fusion, Inc.(BMEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biomea Fusion, Inc.,BMEA,Biomea Fusion, Inc.股票,Biomea Fusion, Inc.股票老虎,Biomea Fusion, Inc.股票老虎国际,Biomea Fusion, Inc.行情,Biomea Fusion, Inc.股票行情,Biomea Fusion, Inc.股价,Biomea Fusion, Inc.股市,Biomea Fusion, Inc.股票价格,Biomea Fusion, Inc.股票交易,Biomea Fusion, Inc.股票购买,Biomea Fusion, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biomea Fusion, Inc.(BMEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}